Why does it matter so much whether a study had a placebo and was double-blind?
Updated: 2026-09-09 · Safety and evidence
Short answer
Without a comparison group you cannot tell whether improvement came from the compound or from time, rest, placebo response or expectation. A control group gives a reference point, randomisation stops the groups forming in biased ways, and blinding keeps participant and assessor expectations from bending the measurement.
In plain English
- Plenty of things improve on their own: injuries, fluctuating symptoms, mood.
- Randomising spreads out the factors you cannot control.
- Double-blind: neither participant nor assessor knows who got what.
- A testimonial or an uncontrolled case series cannot establish cause.
What we know
- The randomised controlled trial is the standard design for establishing causation in clinical research.
- Blinding reduces known measurement and reporting biases.
What we don't know yet
- A well-designed but small or short trial still leaves questions open.
- Much of the evidence behind popular peptides is uncontrolled.
Sources
External links to official sources or peer-reviewed studies.